Avricore Health Inc. (AVCR.V)

0.1550 -0.0150 (-8.82%) At close: 03:59PM EDT

Avricore Health Inc.

789 West Pender Street
Suite 1120
Vancouver, BC V6C 1H2
Canada
604-773-8943
https://avricore.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Hector Bremner	CEO & Director	261.22k	N/A	1982
Ms. Kiriaki Smith CPA, CFO, CGA, CPA	CFO & Corporate Secretary	144.18k	N/A	1967
Mr. Rodger Seccombe	CTO & Director	261.22k	N/A	1981
Mr. Will Seccombe	Communications Advisor	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

Corporate Governance

Avricore Health Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.